Determination of ability for antiviral to prevent disease and choice of dosing regimen to be used in NHP

Summary
Task 26 Objective To evaluate the ability for antivirals to prevent or minimise SARSCoV2induced disease in hamster month 2630Expected results To identify if a clinically relevant dosing regimen that can prevent SARSCoV2induced disease Such a dosing regimen can be further evaluated in NHPs